Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata without access to the full warning letter text, Vital Rx, Inc. operating as Atlantic Pharmacy and Compounding received an FDA warning on September 26, 2018, regarding drug manufacturing or compounding practices. The company appears to be a pharmacy involved in drug compounding operations, which are subject to FDA oversight. Without the detailed subject line and violation specifics, the exact nature of the compliance issues cannot be determined from this metadata alone, though they likely relate to compounding standards, quality control, or facility operations under FDA drug regulations.